2RGU
Crystal structure of complex of human DPP4 and inhibitor
Summary for 2RGU
Entry DOI | 10.2210/pdb2rgu/pdb |
Descriptor | Dipeptidyl peptidase 4, 2-acetamido-2-deoxy-beta-D-glucopyranose, 8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-d ione, ... (4 entities in total) |
Functional Keywords | peptidase, inhibitor, aminopeptidase, glycoprotein, hydrolase, membrane, protease, secreted, serine protease, signal-anchor, transmembrane |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 2 |
Total formula weight | 173297.76 |
Authors | Nar, H.,Himmelsbach, F.,Eckhardt, M. (deposition date: 2007-10-05, release date: 2007-11-06, Last modification date: 2020-07-29) |
Primary citation | Eckhardt, M.,Langkopf, E.,Mark, M.,Tadayyon, M.,Thomas, L.,Nar, H.,Pfrengle, W.,Guth, B.,Lotz, R.,Sieger, P.,Fuchs, H.,Himmelsbach, F. 8-(3-(R)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes. J.Med.Chem., 50:6450-6453, 2007 Cited by PubMed: 18052023DOI: 10.1021/jm701280z PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.6 Å) |
Structure validation
Download full validation report